We observed a high NOTCH1 mutation rate in plasma in comparison to tumor tissue, which may reveal a role of NOTCH1 modifications in tumor metastasis and highlight the clinical advantage of the plasma in detecting mutation biopsy. The gene discussed is NOTCH1; the disease is neoplasm.